Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-06 - Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers
09:45 - 09:45 | Presenter: Adam J Schoenfeld | Author(s): Joseph Chan, Hira Rizvi, Romel Somwar, Daisuke Kubota, Yahya Daneshbod, Jason Chang, Michael Offin, Maria E. Arcila, Dana Pe'Er, Mark G Kris, Natasha Rekhtman, Gregory J Riely, Marc Ladanyi, Helena A Yu
- Abstract
Loading... -
+
P1.14-12 - A Novel Activating MAP2K1 In-Frame Deletion Mediates Acquired Resistance to ROS1 TKIs in a Patient with ROS1 Fusion-Positive NSCLC
09:45 - 09:45 | Presenter: Hiroki Sato | Author(s): Adam J Schoenfeld, Evan Siau, Ken Suzawa, Christine Yue, Michael Offin, Alexander Drilon, Monika A Davare, Gregory J Riely, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
P1.14-50 - A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Robin Guo | Author(s): Isabel Preeshagul, Adam J Schoenfeld, Caroline G. McCarthy, Alex Makhnin, Andrew J. Plodkowski, Michelle S. Ginsberg, Monika A Davare, Lukas Delasos, Romel Somwar, Maria E. Arcila, Gregory J Riely, Natasha Rekhtman, Marc Ladanyi, Mark G Kris, Alexander Drilon
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-26 - Elucidating Mechanisms of Resistance to Targeted Therapies in Mutant EGFR or KRAS Driven Lung Adenocarcinoma Harboring Dual Loss of p53 and RB1
10:15 - 10:15 | Presenter: Yusuke Inoue | Author(s): Romel Somwar, Marc Ladanyi, William Lockwood
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.01 - Generation and Characterization of Novel Preclinical Disease Models of NSCLC with NRG1 Rearrangements to Improve Therapy
14:30 - 14:35 | Presenter: Eric Gladstone | Author(s): Morana Vojnic, Michael Offin, Lukas Delasos, Allan J. W. Lui, Evan Siau, Hirko Sato, Ryma Benayed, Renate Kurth, Marissa Mattar, Inna Khodos, Elisa De Stanchina, Robert Daly, Alison Schram, Alexander Drilon, Marc Ladanyi, Romel Somwar
- Abstract
Loading...
